Share this post on:

Product Name :
Macitentan/Tadalafil

Search keywords :
3′,5′-Cyclic nucleotide phosphodiesterase

drugId :
null

Target Vo:
Phosphodiesterase 5A

Target Vo Short Name :
PDE5A

Moa_Name:
Phosphodiesterase 5A inhibitors

First Approval Country :
United States

First Approval Date Filter:
2024

Origin Company_Name :
Actelion Pharmaceuticals Ltd

Active Company_Name :
Actelion Pharmaceuticals Ltd

Active Indication_Name:
Pulmonary Arterial Hypertension

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tabalumab Technical Information
Ki-67 Antibody custom synthesis
phospho-PI3 Kinase p110 beta (Ser1070) Antibody: phospho-PI3 Kinase p110 beta (Ser1070) Antibody is an unconjugated, approximately 110-123 kDa, rabbit-derived, anti-phospho-PI3 Kinase p110 beta (Ser1070) polyclonal antibody. phospho-PI3 Kinase p110 beta (Ser1070) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, horse, guinea pig background without labeling.

Share this post on:

Author: Betaine hydrochloride